# US 2023/0057359 A1 · Novel use of steviol

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0057359 A1
- Document ID: US20230057359A1
- Status: Published application
- Kind: A1
- Application number: 17/788,933
- Filed: 2020-12-25
- Published: 2023-02-23
- Earliest claimed: 2019-12-27
- Assignees: Suntory Holdings Limited
- Applicants: Suntory Holdings Limited
- Inventors: Junki YOSHIDA; Tadahiro OHKURI; Koji NAGAO; Yoshiaki YOKOO
- Web page: https://patentgrep.com/patent/US20230057359A1

## CPC

- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A23L 2/52: Adding ingredients (adding preservatives A23B70/10)
- A23L 2/60: Sweeteners
- A23L 27/36: {Terpene glycosides}
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 31/704: attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin {(digitoxin A61K31/7048)}
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/06: Antihyperlipidemics
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a composition which contains a steviol and/or steviol glycoside, and is for inhibiting the accumulation of fat, promoting lipolysis, reducing blood glucose level, enhancing the intake of glucose, improving the metabolism of glucose, or treating alcoholic liver disease or non-alcoholic fatty liver disease.

## Claims

### Claim 1

A composition for use in the suppression of fat accumulation and/or in the promotion of lipolysis, the composition comprising steviol and/or steviol glycoside.

### Claim 2 (depends on 1)

The composition for use according to claim 1 for use in the prevention of obesity, in the improvement of obesity and/or in the reduction of body fat.

### Claim 3 (depends on 1, 2)

The composition for use according to claim 1 or 2 for a subject free of diabetes mellitus that responds to insulin therapy.

### Claim 4

A composition for use in the reduction of blood glucose level, in the promotion of sugar uptake and/or in the improvement of sugar metabolism in a subject having insulin resistance, the composition comprising steviol and/or steviol glycoside.

### Claim 5

A composition for use in the treatment of alcoholic liver disease or nonalcoholic fatty liver disease, the composition comprising steviol and/or steviol glycoside.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The composition for use according to any one of claims 1 to 5 for oral ingestion.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The composition for use according to any one of claims 1 to 6 which is a beverage.
